Akamai Technologies Insider Sold Shares Worth $467,900, According to a Recent SEC Filing-March 2024-www.financetom.com

Akamai Technologies Insider Sold Shares Worth $467,900, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Akamai Technologies Insider Sold Shares Worth $467,900, According to a Recent SEC Filing

May 15, 2024 2:19 PM

04:52 PM EDT, 05/15/2024 (MT Newswires) -- Anthony P Williams, Executive Vice President and Chief Human Resources Officer, on May 14, 2024, sold 5,000 shares in Akamai Technologies ( AKAM ) for $467,900. Following the Form 4 filing with the SEC, Williams has control over a total of 9,938 shares of the company, with 9,938 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1086222/000108622224000170/xslF345X03/wk-form4_1715806071.xml

Price: 95.95, Change: -0.03, Percent Change: -0.03

Previous page： Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why Next page： Medpace Holdings Insider Sold Shares Worth $3,474,987, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why

Nov 3, 2025

Sarepta Therapeutics Inc ( SRPT ) shares are plunging in extended trading Monday after the company reported third-quarter results and provided an update on its ESSENCE study. SRPT shares are sliding on disappointing news. Find out why here. What To Know: Sarepta reported third-quarter revenue of $399.36 million, beating analyst estimates of $338.71 million, according to Benzinga Pro. The company reported...

Medpace Holdings Insider Sold Shares Worth $3,474,987, According to a Recent SEC Filing

Nov 3, 2025

04:58 PM EST, 11/03/2025 (MT Newswires) -- Fred B Davenport Jr, Director, on October 30, 2025, sold 5,972 shares in Medpace Holdings ( MEDP ) for $3,474,987. Following the Form 4 filing with the SEC, Davenport has control over a total of 5,498 common shares of the company, with 3,498 shares held directly and 2,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1668397/000118115425000004/xslF345X05/wk-form4_1762206393.xml...

Uipath Insider Sold Shares Worth $730,188, According to a Recent SEC Filing

Nov 3, 2025

04:59 PM EST, 11/03/2025 (MT Newswires) -- Daniel Dines, 10% Owner, Director, CEO and Chairman, on November 03, 2025, sold 45,000 shares in Uipath ( PATH ) for $730,188. Following the Form 4 filing with the SEC, Dines has control over a total of 29,378,585 Class A common shares of the company, with 29,378,585 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1734722/000185576725000032/xslF345X05/primarydocument.xml...

Denny’s Corporation to be Acquired by TriArtisan Capital Advisors, Treville Capital Group and Yadav Enterprises in $620 Million Transaction

Nov 3, 2025

Denny’s Stockholders to Receive $6.25 Per Share in Cash, Delivering Significant, Near-Term and Certain Cash Value Purchase Price Represents Premium of 52.1% to Closing Price on Monday, November 3 and 36.8% Premium to 90-Day VWAP SPARTANBURG, S.C. and NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Denny’s Corporation (the “Company” or “Denny’s”) , owner and operator of Denny’s Inc. and...